FDA Approved: LUMAKRAS — Supplemental Application (Amgen Inc)

View source ↗

Summary

FDA approved a supplemental application for LUMAKRAS (sotorasib) from Amgen, signaling a regulatory update to the drug's labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• LUMAKRAS (sotorasib)

Snippet

SUPPL AP for LUMAKRAS (SOTORASIB)